Patents/Assignees

Regeneron Pharmaceuticals, Inc.

492 patents in portfolio

US12583939utility2026
Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
0 cites
US12584174utility2026
Treatment of Psoriasis with Interferon Induced Helicase C Domain 1 (IFIH1) Inhibitors
0 cites
US12583914utility2026
Methods of Treating Allergy Using Anti-bet V 1 Antibodies
0 cites
US12577304utility2026
Anti-cd3 Antibodies with Low Binding Affinity
0 cites
US12577326utility2026
Recombinant Cell Surface Capture Proteins
0 cites
US12577528utility2026
Taurine Supplemented Cell Culture Medium and Methods of Use
0 cites
US12577547utility2026
PDCD-1 Homing Endonuclease Variants
0 cites
US12577562utility2026
Treatment of Glaucoma with Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) Inhibitors
0 cites
US12570516utility2026
Systems and Methods for Use in Dispensing Biopharmaceutical Materials
0 cites
US12570756utility2026
Methods of Use of Anti-cd45 Antibodies and Conjugates Thereof
0 cites
US12570764utility2026
Anti-muc16 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind MUC16 and CD3, and Uses Thereof
0 cites
US12571027utility2026
Methods of Associating Genetic Variants with a Clinical Outcome in Patients Suffering from Age-related Macular Degeneration Treated with Anti-vegf
0 cites
US12571797utility2026
Liquid Chromatography Assay for Determining AAV Capsid Ratio
0 cites
USD1116103design2026
Dose Delivery Device
0 cites
US12565667utility2026
CHO Integration Sites and Uses Thereof
0 cites
US12564640utility2026
Protein-antiviral Compound Conjugates
0 cites
US12564651utility2026
Radiolabeled Anti-pd-l1 Antibodies for Immuno-pet Imaging
0 cites
US12559576utility2026
CD20-PD1 Binding Molecules and Methods of Use Thereof
0 cites
US12559551utility2026
Stabilized Formulations Containing Anti-angptl3 Antibodies
0 cites
US12561795utility2026
Assembly Line with Integrated Electronic Visual Inspection
0 cites

← PreviousPage 2 of 25Next →